ACCC logo
Facebook  LinkedIn  Twitter  ACCC Youtube Channel  ACCCBuzz blog

Association of Community Cancer Centers

The leading education and advocacy organization for the multidisciplinary cancer team

ACCCBuzz Blog  Find a Cancer Program  Log in to MyNetwork

Home > Resources > Venous Thromboembolism > Overview

Venous Thromboembolism: Identifying Cancer Patients at Risk

Overview

Venous thromboembolism (VTE) prevention in cancer patients is a critical unmet need. ACCC is conducting an initiative focused on examining the VTE protocols for cancer patients in both the inpatient and outpatient settings of care.

Caring for cancer patients who are at risk for VTE presents unique challenges for community-based cancer care providers. Identifying patients at risk for VTE is particularly challenging. Care coordination of at-risk patients across care settings is crucial.

With this initiative ACCC aims to understand the barriers to identifying cancer patients at risk of VTE, approaches to facilitate the identification of these patients, as well as identifying tools and resources to help ensure evaluations and identification occur. Learn more about this project.

Identifying Patients at Risk: Key Findings

VTE-Identifying Cancer Patients at RiskTo help inform this project, ACCC conducted a multidisciplinary focus group and membership survey on how cancer programs manage patients at high risk for developing VTE.

This new publication summarizes focus group findings and survey results, discusses potential issues around identifying and treating VTE, and identifies opportunities for improvement regarding outpatient VTE risk assessment, prophylaxis, and management in the community setting. Plus, gain best practices for patient education and patient monitoring.

Fast Facts About VTE

  • Addressing VTE prevention is a huge unmet need in oncology.
  • All patients with active cancer have increased risk of VTE. But risk is higher for:
    • Pancreatic cancer, lymphoma, malignant brain tumors, cancer of the liver, leukemia, multiple myeloma, and colorectal and other digestive cancers
    • Patients whose cancer has spread to other parts of the body
    • Cancer patients receiving chemotherapy
  • Cancer patients with VTE face much worse outcomes than those with cancer alone.
  • Each year more people die from complications of venous thromboembolism than motor vehicle accidents, breast cancer, and HIV combined.
  • VTE is one of the most prevalent medical problems today, with an annual incidence of 80 cases per 100,000.
  • Most common risk factors for VTE are malignancy, surgery, immobility, obesity, and previous VTE. Each is found in 20-30% of patients.

Access more information and resources related to VTE.

Copyright © 2017 Association of Community Cancer Centers. All Rights Reserved.
1801 Research Boulevard, Suite 400, Rockville, MD 20850  |  Tel.: 301.984.9496  |  Fax: 301.770.1949

CONTACT US